Back to top
more

SiBone (SIBN)

(Delayed Data from NSDQ)

$16.55 USD

16.55
720,502

+1.65 (11.07%)

Updated Aug 23, 2024 04:00 PM ET

After-Market: $16.52 -0.03 (-0.18%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (81 out of 251)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Teleflex (TFX) Picked for Vizient Innovative Technology Exchange

Teleflex (TFX) gets selected to exhibit Arrow VPS Rhythm DLX Device and Arrow PICCs preloaded with the NaviCurve Stylet at the Vizient Innovative Technology Exchange.

Alcon (ALC) Gains From Innovation & International Expansion

Alcon's (ALC) Surgical business continues to gain from diverse portfolio and incremental innovation.

Teleflex (TFX) New Survey Highlights BPH Impact Life Quality

Teleflex's (TFX) survey results highlight how crucial it is for men to consult a urologist if they have strange or troublesome urine symptoms.

Charles River (CRL) Announces Partnership With Related Sciences

Charles River's (CRL) new collaboration is likely to leverage the AI-powered drug discovery and development platform, Logica.

Here's Why You Should Retain Insulet (PODD) Stock for Now

Investors continue to be optimistic about Insulet (PODD) on the strength of the Omnipod 5 AID system.

Quest Diagnostics (DGX) to Aid Health Equity With New Pact

Quest Diagnostics (DGX) and Americares will provide 10 clinics with no-cost diagnostic services for a year to help patients manage chronic disease.

Here's Why You Should Retain SmileDirectClub (SDC) Stock for Now

Investors are optimistic about SmileDirectClub (SDC) on the latest technology enhancements and upbeat guidance.

Chemed (CHE) Faces Macroeconomic Woes, Tough Competition

Inflationary trend, increased logistics costs and higher employee-related expenses continue to hurt Chemed's (CHE) growth.

Vicarious Surgical (RBOT) to Broaden User Network With New Deal

Vicarious Surgical's (RBOT) partnership with Intermountain Health is likely to help the company gain access to Intermountain Health's extensive network.

CVS Health's (CVS) New COVID-19 Vaccine Available at Its Stores

CVS Health's (CVS) updated mRNA COVID-19 vaccine is now available at all its pharmacy locations.

Walgreens (WBA) Expands Primary Care Research With New Pact

Walgreens (WBA) will reach more communities quickly and provide comprehensive, cost-effective care with the new collaboration.

SmileDirectClub (SDC) New Alliances Aid, Macro Woes Hurt

SmileDirectClub (SDC) is focused on developing transformative innovations to serve the growing needs of the current customer base and expanded segments of higher-income demographics.

Here's Why You Should Invest in Edward Lifesciences (EW) Now

Investors continue to be optimistic about Edward Lifesciences (EW) on the strength of TAVR and a solid balance sheet.

Syneos Health (SYNH) Declares Strategic Partnership With Oracle

Syneos Health (SYNH) announces an expanded collaboration with Oracle to accelerate patient recruitment capabilities.

Bruker (BRKR) Inks Fraport Framework Contract for ETD Systems

Bruker's (BRKR) DE-tector flex system uses a non-radioactive ionization source and is approved by national regulatory bodies and ECAC.

Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now

Investors are optimistic about Myriad Genetics (MYGN) on improvement in testing volume across all its businesses.

Insulet (PODD) Expands Omnipod 5 Even As Macro Woes Linger

Insulet's (PODD) international expansion efforts are aligned with its long-term growth profile.

QIAGEN's (QGEN) New API Streamlines Access to BKB Data

QIAGEN (QGEN) introduces API to give easier access to the QIAGEN Biomedical Knowledge Base.

NanoString (NSTG) Grows in Translational Research With CRO Deals

According to NanoString (NSTG), SMI's unique ability to interrogate both RNA and proteins at ultra-high plex with subcellular resolution has made it a one-of-a-kind tool.

Thermo Fisher (TMO) to Advance Clinical Research With New Pact

Thermo Fisher's clinical research division will aid in increasing community health clinics' capacity to participate in clinical studies.

Alcon (ALC) Surgical Advances With New Data on AcrySof IQ Vivity

Alcon's (ALC) Vivity Registry study data highlights the lens's versatility in treating a wide range of patients.

Align Technologies (ALGN) Brings New Upgrades for Oral Health

Align Technologies (ALGN) introduces a series of software innovations to accelerate the digital practice transformation.

Globus Medical (GMED) Launches NuVasive's NSO in Global Market

Globus Medical's (GMED) Precice Bone Transport is a less intrusive treatment that reduces complications for both the patient and the surgeon and is designed for various bone abnormalities.

National Vision (EYE) Gains From Store Opening Amid Macro Woes

In terms of store expansion, National Vision (EYE) continues to see a sizable new opportunity with growth for the coming years.

Has SiBone (SIBN) Outpaced Other Medical Stocks This Year?

Here is how Si-Bone (SIBN) and Alpine Immune Sciences, Inc. (ALPN) have performed compared to their sector so far this year.